Clinical and molecular characteristics in three families with biallelic mutations in IGHMBP2
Clinical and molecular characteristics in three families with biallelic mutations in IGHMBP2
复制标题
DOI:
10.1016/j.nmd.2016.06.457
复制
发表时间:
2016-09-01
影响因子:
2.8
通讯作者:
Stromme, Petter
中科院分区:
文献类型:
--
作者:
Pedurupillay, Christeen Ramane J.;Amundsen, Silja S.;Stromme, Petter
Biallelic mutations in IGHMBP2 cause spinal muscular atrophy with respiratory distress type 1 (SMARD1) or Charcot Marie Tooth type 2S (CMT2S). We report three families variably affected by IGHMBP2 mutations. Patient 1, an 8-year-old boy with two homozygous variants: c.2T>C and c.861C>G, was wheelchair bound due to sensorimotor axonal neuropathy and chronic respiratory failure. Patient 2 and his younger sister, Patient 3, had compound heterozygous variants: c.983_987delAAGAA and c.1478C>T. However, clinical phenotypes differed markedly as the elder with sensorimotor axonal neuropathy had still unaffected respiratory function at 4.5 years, whereas the younger presented as infantile spinal muscular atrophy and died from relentless respiratory failure at 11 months. Patient 4, a 6-year-old girl homozygous for IGHMBP2 c.449+1G>T documented to result in two aberrant transcripts, was wheelchair dependent due to axonal polyneuropathy. The clinical presentation in Patients 1 and 3 were consistent with SMARD1, whereas Patients 2 and 4 were in agreement with CMT2S. (C) 2016 The Authors. Published by Elsevier B.V.